Cortexyme, Inc. (CRTX) Social Stream



Cortexyme, Inc. (CRTX): $1.95

0.05 (+2.63%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add CRTX to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#297 of 402

in industry

CORTEXYME INC (CRTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CORTEXYME INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 4 $150 $17 $54.25 $1.95 2682.05%
2022-01-10 3 $150 $17 $65.666 $1.95 3267.49%
2022-01-26 4 $150 $6 $62 $1.95 3079.49%
2022-03-02 4 $30 $6 $16 $1.95 720.51%
2022-03-03 4 $30 $5 $15.666 $1.95 703.38%
2022-04-09 4 $15 $5 $10.666 $1.95 446.97%
2022-05-27 4 $15 $4 $10.333 $1.95 429.9%

The Trend in the Analyst Price Target


CRTX's average price target has moved down $60.96 over the prior 51 weeks.

CRTX reports an average of 204.48% for its upside potential over the past 42 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-11 8 221 14 97.710 91.08 7.28%
2021-11-12 3 150 17 65.666 14.26 360.49%
2022-01-10 3 150 17 65.666 11.58 467.06%
2022-03-03 4 30 5 15.666 4.30 264.33%
2022-03-22 4 15 5 10.666 6.15 73.43%

CRTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.75 1 0 2 0 0 4

The Trend in the Broker Recommendations


Over the past 61 days, CRTX's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • CRTX has a greater upside potential (average analyst target price relative to current price) than 774.82% of all US stocks.
  • In terms of how CORTEXYME INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -667.63% of that group.
  • CORTEXYME INC's number of analysts covering the stock is higher than 108.38% of stocks in the mid market cap category.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, CORTEXYME INC's average analyst price target is higher than 327.11% of them.

In the Pharmaceutical Products industry, CCCC, BEAM, and BCRX are the three stocks most similar to CORTEXYME INC regarding the price target and analyst recommendation information presented here.

Is CRTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!